EGFR (Epidermal Growth Factor Receptor)
EGFR
Receptor tyrosine kinase driving cell proliferation, commonly mutated in NSCLC.
Função
Activating mutations drive oncogenic signaling. Targeted by TKIs (erlotinib, osimertinib) and antibodies (cetuximab).
Medicamentos que Atuam neste Alvo
| Medicamento | Ação | Primário |
|---|---|---|
| Trastuzumab | Antagonist | Sim |